| MTEN 0.0401 13.60% | OCG 0.0104 -11.86% | SOXS 2.091 -8.29% | IVP 0.0581 -29.15% | APLT 0.1015 1.60% | BNKK 4.3093 55.01% | ZSL 3.0699 9.06% | SLV 81.2251 -3.94% | SOXL 60.085 8.50% | NVDA 186.66 1.92% | PTHL 0.3983 -9.44% | TQQQ 55.35 2.82% | PCLA 0.2039 -7.74% | INTC 49.95 2.52% | JTAI 0.4932 8.49% | DVLT 0.74 3.04% | MASK 0.3 -0.17% | TSLL 18.445 2.08% | OCUL 12.0799 9.12% | SIDU 3.8793 3.45% | BYND 1.105 14.88% | SXTC 0.1011 4.98% | ASST 0.9772 -5.13% | TSM 340.925 4.22% | MSTX 4.936 -5.08% | RILY 10.34 37.14% | SQQQ 65.05 -2.82% | AMD 232.6 4.03% | QQQ 625.485 0.96% | SAFX 0.1217 -11.36% | ASBP 0.0547 -6.81% | ROLR 21.4199 14.79% | GTBP 0.7257 9.95% | BMNR 32.07 -1.79% | CGTL 3.47 38.80% | SPY 694 0.53% | CRML 16.885 -5.80% | ASNS 0.4789 9.51% | NOK 6.635 4.32% | CRWV 96.8 7.80% | ONDS 13.42 -1.03% | IBIT 54.6242 -1.47% | ETHA 25.355 -0.92% | RGTI 25.88 0.62% | MU 339.62 1.88% | GPUS 0.3182 -0.50% | RZLV 4.139 1.95% | XLE 47.29 -1.60% | GRAB 4.56 -1.51% | PLUG 2.395 1.91%

Wolfe Research Upgrades Trex, Citing Valuation Disconnect After Selloff

Wolfe Research upgraded Trex (NYSE: TREX) to Outperform from Peer Perform and set a $47 price target. Shares rose more than 1% in pre-market trading on Wednesday.

The firm noted that Trex shares had fallen nearly 50% in 2025, underperforming the broader building products group by roughly 27 percentage points. While Wolfe acknowledged investor concerns about future market share gains following James Hardie’s acquisition of AZEK, it said the magnitude of the selloff had created an excessive valuation discount.

Trex was trading at 12.3x Wolfe’s 2026 EBITDA estimate, representing a 44% discount to its long-term average multiple and a 53% discount to its 2018–2024 average. Wolfe said returns had declined as Trex invested in capacity, carried higher inventory under its even-flow production model, and increased SG&A spending amid muted market growth. Despite this, the firm projected a 16% ROIC in 2026, the second-highest in its coverage universe, and said the decking industry’s growth profile warranted a premium valuation. The $47 target implied a roughly 15x EV/EBITDA multiple.

Published on: January 7, 2026